Literature DB >> 19591927

Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses.

Grzegorz Garbacz1, Berit Golke, Ralph-Steven Wedemeyer, Marie Axell, Erik Söderlind, Bertil Abrahamsson, Werner Weitschies.   

Abstract

In order to improve the predictability of dissolution testing new apparatuses have been proposed that mimic hydrodynamic and mechanical conditions in the gastrointestinal tract. In this study tested were four different nifedipine extended release (ER) formulations using the paddle apparatus and the reciprocating cylinder as pharmacopoeial test devices as well as two newly developed test apparatuses: the rotating beaker apparatus and the dissolution stress test apparatus. Investigated were Adalat OROS in strengths of 30 and 60 mg, and two hydrophilic matrix formulations: 60 mg nifedipine Coral and Nifedipin Sandoz 40 mg retard. The results demonstrate that the dissolution characteristic of the ER tablets is strongly dependent on the applied test conditions. The dosage form related food effects for Coral 60 mg tablets that were previously observed in human bioequivalence studies could be predicted with the two non-compendial dissolution test devices. The dissolution of Sandoz 40 mg tablets was very sensitive to all applied test conditions. The stable drug delivery characteristics of Adalat OROS observed in numerous in vivo studies was also observed in all of the dissolution tests. In conclusion, the present study shows that besides pH dependency the aspect of the mechanical robustness may be an essential factor affecting the dissolution characteristic of hydrogel matrix formulations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19591927     DOI: 10.1016/j.ejps.2009.06.010

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  7 in total

1.  A semi-mechanistic modeling strategy to link in vitro and in vivo drug release for modified release formulations.

Authors:  Martin Bergstrand; Erik Söderlind; Ulf G Eriksson; Werner Weitschies; Mats O Karlsson
Journal:  Pharm Res       Date:  2011-09-27       Impact factor: 4.200

2.  Silicone adhesive matrix of verapamil hydrochloride to provide pH-independent sustained release.

Authors:  Gaurav Tolia; S Kevin Li
Journal:  AAPS PharmSciTech       Date:  2014-02       Impact factor: 3.246

3.  Achieving antral grinding forces in biorelevant in vitro models: comparing the USP dissolution apparatus II and the dynamic gastric model with human in vivo data.

Authors:  Maria Vardakou; Annalisa Mercuri; Susan A Barker; Duncan Q M Craig; Richard M Faulks; Martin S J Wickham
Journal:  AAPS PharmSciTech       Date:  2011-05-10       Impact factor: 3.246

4.  The improvement of the dissolution rate of ziprasidone free base from solid oral formulations.

Authors:  Daniel Zakowiecki; Krzysztof Cal; Kamil Kaminski; Karolina Adrjanowicz; Lech Swinder; Ewa Kaminska; Grzegorz Garbacz
Journal:  AAPS PharmSciTech       Date:  2015-01-16       Impact factor: 3.246

5.  Release characteristics of quetiapine fumarate extended release tablets under biorelevant stress test conditions.

Authors:  Grzegorz Garbacz; Anna Kandzi; Mirko Koziolek; Jarosław Mazgalski; Werner Weitschies
Journal:  AAPS PharmSciTech       Date:  2013-12-03       Impact factor: 3.246

6.  Sulfonic Acid Derivative-Modified SBA-15, PHTS and MCM-41 Mesoporous Silicas as Carriers for a New Antiplatelet Drug: Ticagrelor Adsorption and Release Studies.

Authors:  Michał Moritz; Małgorzata Geszke-Moritz
Journal:  Materials (Basel)       Date:  2020-06-29       Impact factor: 3.623

7.  Design and evaluation of an extended-release matrix tablet formulation; the combination of hypromellose acetate succinate and hydroxypropylcellulose.

Authors:  Sachiko Fukui; Hideki Yano; Shuichi Yada; Tsuyoshi Mikkaichi; Hidemi Minami
Journal:  Asian J Pharm Sci       Date:  2016-11-18       Impact factor: 6.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.